Oliver Sartor

Oliver Sartor

UNVERIFIED PROFILE

Are you Oliver Sartor?   Register this Author

Register author
Oliver Sartor

Oliver Sartor

Publications by authors named "Oliver Sartor"

Are you Oliver Sartor?   Register this Author

99Publications

2603Reads

38Profile Views

Germline BLM mutations and metastatic prostate cancer.

Prostate 2020 Feb 5;80(2):235-237. Epub 2019 Nov 5.

Tulane Cancer Center, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009322PMC
February 2020

End of an era for erythropoiesis stimulating agents in oncology.

Int J Cancer 2020 Feb 9. Epub 2020 Feb 9.

Medical University of the University of South Carolina, Charleston, South Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32917DOI Listing
February 2020

Why is prostate cancer incidence rising in young men?

Authors:
Oliver Sartor

Cancer 2020 Jan 25;126(1):17-18. Epub 2019 Sep 25.

Tulane Medical School, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32497DOI Listing
January 2020

Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials.

Eur J Cancer 2020 Jan 11;125:142-152. Epub 2019 Dec 11.

Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.10.029DOI Listing
January 2020

Next Generation of Androgen Deprivation Therapy Combined With Radiotherapy for N0 M0 Prostate Cancer.

Cancer J 2020 Jan/Feb;26(1):21-28

From the Department of Hematology and Medical Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000428DOI Listing
January 2020

Inherited DNA-repair gene mutations in African American men with prostate cancer.

Oncotarget 2020 Jan 28;11(4):440-442. Epub 2020 Jan 28.

Invitae Corporation, Genetics, San Francisco, California, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996909PMC
January 2020

High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer.

Clin Genitourin Cancer 2019 12 19;17(6):476-479. Epub 2019 Aug 19.

Tulane University School of Medicine, New Orleans, LA; Tulane Cancer Center, New Orleans, LA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.07.022DOI Listing
December 2019

Eradication of BRAF K601E Mutation in Metastatic Castrate-resistant Prostate Cancer Treated With Cabazitaxel and Carboplatin: A Case Report.

Clin Genitourin Cancer 2019 Dec 19. Epub 2019 Dec 19.

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA; Hematology-Oncology Section, Department of Medicine, Tulane University School of Medicine, New Orleans, LA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.12.015DOI Listing
December 2019

Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate Cancer.

Int J Radiat Oncol Biol Phys 2019 11 2;105(3):621-627. Epub 2019 Jul 2.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.06.2510DOI Listing
November 2019

TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.

Clin Genitourin Cancer 2019 Nov 6. Epub 2019 Nov 6.

Tulane University School of Medicine, New Orleans, LA; Tulane Cancer Center, New Orleans, LA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.10.022DOI Listing
November 2019

Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?

Minerva Urol Nefrol 2019 Oct 25;71(5):445-456. Epub 2019 Jul 25.

Department of Urology, Andros Men's and Gynos Women's Health Institutes, Arnhem, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0393-2249.19.03420-9DOI Listing
October 2019

Reply to J.B. Aragon-Ching.

J Clin Oncol 2019 Sep 1;37(25):2297-2298. Epub 2019 Jul 1.

Seth A. Rosenthal, MD, Sutter Medical Group and Sutter Cancer Centers, Sacramento, CA; Chen Hu, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Oliver Sartor, MD, Tulane University Health Services Center, New Orleans, LA; Felix Y. Feng, MD, University of California at San Francisco, San Francisco, CA; and Howard M. Sandler, MD, MS, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01332DOI Listing
September 2019

Synergistic Interactions: Targeted Radiopharmaceuticals and Homologous Recombination Repair Alterations in Prostate Cancer.

Authors:
Oliver Sartor

Eur Urol 2019 Aug 1;76(2):177-178. Epub 2018 Dec 1.

Cancer Center, Tulane Medical School, New Orleans, LA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.11.041DOI Listing
August 2019

Germline Variants in Highly Selected Patients With Prostate Cancer-In Reply.

JAMA Oncol 2019 Jul 11. Epub 2019 Jul 11.

Invitae Corporation, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.2120DOI Listing
July 2019

Distress among African American and White adults with cancer in Louisiana.

J Psychosoc Oncol 2020 Jan-Feb;38(1):63-72. Epub 2019 Jul 19.

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07347332.2019.1634176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980484PMC
July 2019

Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or….

Cancer 2019 06 1;125(11):1777-1788. Epub 2019 Apr 1.

Tulane Cancer Center, Tulane University, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32039DOI Listing
June 2019

Relationship between serum markers and volume of liver metastases in castration-resistant prostate cancer.

Cancer Treat Res Commun 2019 14;20:100151. Epub 2019 May 14.

Tulane Cancer Center, Tulane University School of Medicine, 150 S Liberty St, New Orleans, LA 70112, Unites States; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112, Unites States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24682942183013
Publisher Site
http://dx.doi.org/10.1016/j.ctarc.2019.100151DOI Listing
May 2019

Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer.

BMC Cancer 2019 May 31;19(1):524. Epub 2019 May 31.

Tulane Cancer Center, Tulane University School of Medicine, 1430 Tulane Ave., SL-42, New Orleans, LA, 70112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5729-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544996PMC
May 2019

Biomarkers for Programmed Death-1 Inhibition in Prostate Cancer.

Oncologist 2019 04 12;24(4):444-448. Epub 2018 Dec 12.

Tulane University School of Medicine, New Orleans, Louisiana, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459247PMC
April 2019

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.

Oncologist 2019 03 19;24(3):291-292. Epub 2018 Dec 19.

Tulane Cancer Center, Tulane University Medical School, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519754PMC
March 2019

Androgen deprivation therapy in prostate cancer: new findings and questions for the future.

Authors:
Oliver Sartor

Lancet Oncol 2019 Feb 19;20(2):176-177. Epub 2018 Dec 19.

Tulane Medical School, New Orleans, LA 70112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30893-3DOI Listing
February 2019

The Evolving Role of Prostate-Specific Membrane Antigen-Based Diagnostics and Therapeutics in Prostate Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:321-330. Epub 2019 May 17.

5 Department of Medical Oncology, Tulane University, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_239187DOI Listing
January 2019

Conflicts of Interest, Baselga, and Clinical Trialists.

Authors:
Oliver Sartor

Oncologist 2018 12 24;23(12):1394. Epub 2018 Oct 24.

Departments of Medicine and Urology, Tulane Cancer Center, New Orleans, Louisiana, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292550PMC
December 2018

Advanced prostate cancer update 2018.

Authors:
Oliver Sartor

Asia Pac J Clin Oncol 2018 Nov;14 Suppl 5:9-12

Tulane Cancer Center, New Orleans, LA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ajco.13057
Publisher Site
http://dx.doi.org/10.1111/ajco.13057DOI Listing
November 2018

Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker.

Future Oncol 2018 Oct 21;14(24):2543-2556. Epub 2018 Jun 21.

Departments of Medicine & Urology, Tulane Cancer Center, 1430 Tulane Ave., SL-42, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0087DOI Listing
October 2018

Editorial Comment.

Urology 2018 08 28;118:125-126. Epub 2018 May 28.

Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC; The Southern Network on Adverse Reaction (SONAR) project, the South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, SC; WJB Dorn VA Medical Center, Columbia, SC; The Hollings National Cancer Institute Designated Cancer Center, Medical University of South Carolina, Charleston, SC.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00904295183038
Publisher Site
http://dx.doi.org/10.1016/j.urology.2018.02.050DOI Listing
August 2018

Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer.

Clin Genitourin Cancer 2018 08 1;16(4):313-317. Epub 2018 Jun 1.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673183033
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2018.05.007DOI Listing
August 2018

Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer.

Oncologist 2018 07 26;23(7):791-797. Epub 2018 Apr 26.

Departments of Medicine and Urology, Tulane University School of Medicine, New Orleans, Louisiana, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058331PMC
July 2018

Radium and other alpha emitters in prostate cancer.

Transl Androl Urol 2018 Jun;7(3):436-444

Department of Radiation Oncology, Division of Hematology/Oncology, Tulane University School of Medicine, New Orleans, LA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2018.02.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043743PMC
June 2018

Curing More Prostate Cancer: Thinking Through the Options.

Authors:
Oliver Sartor

J Clin Oncol 2018 05 6;36(15):1466-1468. Epub 2018 Apr 6.

Oliver Sartor, Tulane Medical School, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.4835DOI Listing
May 2018

Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.

Am Soc Clin Oncol Educ Book 2018 May;38:372-381

From the University of Washington, Seattle, WA; University of Pennsylvania, Philadelphia, PA; University of Rochester, Rochester, NY; Tulane Cancer Center, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_205441DOI Listing
May 2018

Metastatic Prostate Cancer.

N Engl J Med 2018 04;378(17):1653-1654

Institute of Cancer Research, London, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1803343DOI Listing
April 2018

Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity.

Authors:
Oliver Sartor

Oncologist 2018 01 20;23(1). Epub 2017 Nov 20.

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759825PMC
January 2018

Extreme Prostate-Specific Antigen Response to Infusional 5-Flourouracil in Castrate-Resistant Prostate Cancer.

Oncologist 2018 03 19;23(3):383-385. Epub 2017 Dec 19.

Tulane Cancer Center and Tulane University School of Medicine, New Orleans, Louisiana, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905692PMC
March 2018

Editorial Comment.

Urology 2018 03 27;113:144-145. Epub 2017 Dec 27.

Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC; The Southern Network on Adverse Reaction (SONAR) Project, The South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, SC; WJB Dorn VA Medical Center, Columbia, SC; The Hollings National Cancer Institute Designated Cancer Center, Medical University of South Carolina, Charleston, WV.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.08.068DOI Listing
March 2018

Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.

Eur Urol 2018 02 30;73(2):e32-e33. Epub 2017 Aug 30.

Department Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Department of Oncology, University of Bern, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.08.014DOI Listing
February 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

Metastatic Prostate Cancer.

N Engl J Med 2018 02 7;378(7):645-657. Epub 2018 Feb 7.

From Tulane Medical School, New Orleans (O.S.); and the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London (J.S.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMra1701695DOI Listing
February 2018

Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity.

Authors:
Oliver Sartor

Oncologist 2018 01 20;23(1). Epub 2017 Nov 20.

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759825PMC
January 2018

Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature.

Curr Med Res Opin 2017 11 10;33(11):1995-2008. Epub 2017 Jul 10.

d Tulane University Department of Urology , New Orleans , LA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2017.1341869DOI Listing
November 2017

Editorial Comment.

Urology 2017 11 21;109:16-17. Epub 2017 Sep 21.

Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC; The Southern Network on Adverse Reaction (SONAR) Project, the South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, SC; WJB Dorn VA Medical Center, Columbia, SC; The Hollings National Cancer Institute Designated Cancer Center, Medical University of South Carolina, Charleston, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.04.063DOI Listing
November 2017

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.

JCO Clin Cancer Inform 2017 11;1:1-15

Fatemeh Seyednasrollah and Laura L. Elo, Turku Centre for Biotechnology; University of Turku; Åbo Akademi University, Turku, Finland; Devin C. Koestler, University of Kansas Medical Center, Kansas City, KS; Tao Wang, University of Texas Southwestern Medical Center, Dallas, TX; Stephen R. Piccolo, Brigham Young University, Provo; University of Utah, Salt Lake City, Utah, UT; Roberto Vega, Russell Greiner, and Luke Kumar, University of Alberta; Alberta Innovates Centre for Machine Learning, Edmonton, Alberta, Canada; Christiane Fuchs, Helmholtz Zentrum München, Neuherberg; Technische Universität München, Garching, Germany; Eyal Gofer, The Hebrew University, Jerusalem, Israel; Russell D. Wolfinger, SAS Institute, Cary, NC; Kimberly Kanigel Winner and James C. Costello, University of Colorado, Anschutz Medical Campus, Aurora, CO; Chris Bare, Elias Chaibub Neto, Thomas Yu, Thea Norman, and Justin Guinney, Sage Bionetworks, Seattle, WA; Liji Shen and Fang Liz Zhou, Sanofi, Bridgewater, NJ; Kald Abdallah, AstraZeneca, Gaithersburg, MD; Gustavo Stolovitzky, IBM Research, Yorktown Heights; Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Howard R. Soule, Prostate Cancer Foundation, Santa Monica; Charles J. Ryan, University of California, San Francisco, CA; Christopher J. Sweeney, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Oliver Sartor, Tulane University, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874023PMC
November 2017

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.

J Clin Oncol 2017 Oct 28;35(28):3189-3197. Epub 2017 Jul 28.

Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.1068DOI Listing
October 2017

Abiraterone in Metastatic Prostate Cancer.

N Engl J Med 2017 10;377(17):1694-5

Tulane University School of Medicine, New Orleans, LA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1711029DOI Listing
October 2017

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

J Clin Oncol 2017 09 10;35(27):3097-3104. Epub 2017 Aug 10.

Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.9987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652387PMC
September 2017

Isotope Therapy for Castrate-Resistant Prostate Cancer: Unique Sequencing and Combinations.

Authors:
Oliver Sartor

Cancer J 2016 Sep/Oct;22(5):342-346

From the Departments of Medicine & Urology, Tulane Medical School, New Orleans, LA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-201609000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0000000000000218DOI Listing
August 2017

Prostate-specific Antigen Response and Eradication of Androgen Receptor Amplification with High-dose Testosterone in Prostate Cancer.

Eur Urol 2017 06 28;71(6):997-998. Epub 2016 Dec 28.

Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.12.010DOI Listing
June 2017

Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223.

Clin Genitourin Cancer 2017 06 29;15(3):e501-e502. Epub 2016 Dec 29.

Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.12.028DOI Listing
June 2017

Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

CA Cancer J Clin 2017 05 21;67(3):245-253. Epub 2017 Feb 21.

Chief of Urologic Oncology, Department of Urology, University of Washington, and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375094PMC
May 2017

Navigating the evolving therapeutic landscape in advanced prostate cancer.

Urol Oncol 2017 05 7;35S:S1-S13. Epub 2017 Mar 7.

Department of Medicine, Tulane Cancer Center, New Orleans, LA; Department of Urology, Tulane Cancer Center, New Orleans, LA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.01.020DOI Listing
May 2017

Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy.

Clin Genitourin Cancer 2017 04 20;15(2):e289-e298. Epub 2016 Aug 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.08.015DOI Listing
April 2017

Editorial Comment.

Authors:
Oliver Sartor

Urology 2017 04 6;102:171-172. Epub 2017 Mar 6.

Cancer Research, Department of Medicine and Urology, Tulane University School of Medicine, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.10.045DOI Listing
April 2017

Advantages of a Truly Open-Access Data-Sharing Model.

N Engl J Med 2017 Mar;376(12):1178-1181

From the Dana-Farber Cancer Institute, Brigham and Women's Hospital (M.M.B.), and Massachusetts General Hospital Cancer Center (B.A.C.), Boston; Tulane Medical School, New Orleans (O.S.); Pfizer (M.L.R.) and Carmine Research (C.H.-J.), New York; Food and Drug Administration, Silver Spring, MD (S.K.); Amgen, Thousand Oaks, CA (D.M.R.); and Project Data Sphere, Cary, NC (M.J.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsb1702054DOI Listing
March 2017

Estrogen-Mediated Activation of H875Y Androgen Receptor Mutation in a Prostate Cancer Patient.

Clin Genitourin Cancer 2017 02 22;15(1):e111-e113. Epub 2016 Jul 22.

Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.07.015DOI Listing
February 2017

Exceptional Duration of Radium-223 in Prostate Cancer With a BRCA2 Mutation.

Clin Genitourin Cancer 2017 02 17;15(1):e69-e71. Epub 2016 Sep 17.

Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA; Department of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.09.001DOI Listing
February 2017

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

N Engl J Med 2017 02;376(5):417-428

From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444881PMC
February 2017

Generic drugs in oncology - Authors' reply.

Lancet Oncol 2017 02;18(2):e64

University of Nebraska School of Medicine, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30016-5DOI Listing
February 2017

Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance.

Mol Cancer Res 2017 01 26;15(1):59-68. Epub 2016 Sep 26.

College of Life Sciences, National Engineering Laboratory for AIDS Vaccine, Jilin University, Changchun, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-16-0236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215946PMC
January 2017

Beyond Just Androgen Deprivation Therapy: Novel Therapies Combined With Radiation.

Semin Radiat Oncol 2017 01 26;27(1):87-93. Epub 2016 Aug 26.

Tulane Cancer Center, Tulane Medical School, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2016.08.003DOI Listing
January 2017

Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.

Lancet Oncol 2017 01;18(1):22-23

MD Anderson Cancer Center and the University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30653-2DOI Listing
January 2017

A Whole Blood Assay for AR-V7 and AR in Patients with Prostate Cancer.

J Urol 2016 12 20;196(6):1758-1763. Epub 2016 Jul 20.

Department of Pathology, Tulane University School of Medicine, New Orleans, Louisiana; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.06.095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161406PMC
December 2016

Generic oncology drugs: are they all safe?

Lancet Oncol 2016 Nov;17(11):e493-e501

Southern Network on Adverse Reactions (SONAR), South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, SC, USA; William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia, SC, USA; Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Medical University of South Carolina School of Medicine and Cancer Center, Charleston, SC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30384-9DOI Listing
November 2016

Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy.

J Urol 2016 Oct 29;196(4):1053-60. Epub 2016 Apr 29.

Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana; Division of Urology, Department of Surgery, Southeast Louisiana Veterans Health Care Services, New Orleans, Louisiana. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.04.075DOI Listing
October 2016

Prostate cancer: What is the optimal treatment sequence for mCRPC?

Authors:
Oliver Sartor

Nat Rev Urol 2016 10;13(11):639-640

Departments of Medicine and Urology, Tulane University School of Medicine, Box SL 42, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2016.205DOI Listing
October 2016

Radiopharmaceuticals: A Path Forward.

Authors:
Oliver Sartor

Eur Urol 2016 09 19;70(3):427-8. Epub 2016 Apr 19.

Departments of Medicine and Urology, Tulane University School of Medicine, New Orleans, LA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.03.056DOI Listing
September 2016

Racial variation in prostate needle biopsy templates directed anterior to the peripheral zone.

Urol Oncol 2016 08 5;34(8):336.e1-6. Epub 2016 May 5.

Department of Urology, Tulane University School of Medicine, New Orleans, LA; Southeast Louisiana Veterans Health Care Services, New Orleans, LA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.03.017DOI Listing
August 2016

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA.

Prostate 2016 07 23;76(10):905-16. Epub 2016 Mar 23.

Academic Urology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071661PMC
July 2016